Respiratory Inhalers market Insights: Increased prevalence of respiratory disorders drives demand for innovative inhaler solutions. US, NY, UNITED STATES, January 23, 2025 /EINPresswire ...

More than half of patients are unsure when their asthma inhaler is empty, with some continuing to use the device, research ...

A review of the literature was conducted to examine the clinical effectiveness of inhaled GSH as a treatment for various pulmonary diseases and respiratory-related conditions. This report also ...

Inhalers may be prescribed to people who have ... According to Elaine Fajardo, MD, Medical Director for Respiratory Therapy and Pulmonologist at Yale Medicine, and Assistant Professor at Yale ...

Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases – specifically, chronic obstructive pulmonary disease (COPD) and asthma.

Respiratory Inhalers Market is estimated to valued at USD 33.11 Bn in 2024 and expected to reach USD 49.10 Bn by 2031, exhibiting CAGR of 5.8% from 2024-2031 BURLINGAME, CA, UNITED STATES ...

“The work we are doing with AstraZeneca developing a respiratory inhaler, with a new near-zero Global Warming Potential propellant, is tremendously important for both the environment and ...

The workshop on Inhalation Technology covers inhalation devices, factors influencing dose delivery and drug deposition, and ways of improving the deposition of inhaled drugs in the lungs.

Manchester, UK, 20 th January 2025 – Chiesi UK & Ireland has published new research in the BMJ Open Respiratory Research, demonstrating that over 50% of UK patients do not know when their inhaler is ...

Chiesi’s research showed that more than 50% of UK patients do not know when their inhaler is empty, with many continuing use ...